Real-World Efficacy of Regdanvimab on Clinical Outcomes in Patients with Mild to Moderate COVID-19

Background: This study aims to evaluate the real-world effectiveness of regdanvimab on clinical outcomes in patients with mild to moderate coronavirus disease 2019 (COVID-19). Methods: This retrospective observational study included 152 patients (89 received regdanvimab and 63 did not) diagnosed wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Taeyun, Joo, Dong-Hyun, Lee, Seung Woo, Lee, Jaejun, Lee, Sang Jin, Kang, Jihun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911404/
https://www.ncbi.nlm.nih.gov/pubmed/35268503
http://dx.doi.org/10.3390/jcm11051412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911404/
https://www.ncbi.nlm.nih.gov/pubmed/35268503
http://dx.doi.org/10.3390/jcm11051412

Ejemplares similares